Page last updated: 2024-08-16

temozolomide and glutamic acid

temozolomide has been researched along with glutamic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Berkutzki, T; Cooper, I; Mohar, B; Ruban, A; Teichberg, VI1
Beck, J; Behringer, SP; Follo, M; Garrelfs, N; Goeldner, JM; Hannibal, L; Heiland, DH; Hofmann, UG; Joseph, K; Kueckelhaus, J; Maier, JP; Pfeifer, D; Ravi, VM; Schnell, O; Sun, N; von Ehr, J; Walch, AK; Will, P1

Other Studies

3 other study(ies) available for temozolomide and glutamic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas.
    Investigational new drugs, 2012, Volume: 30, Issue:6

    Topics: Animals; Antineoplastic Agents, Alkylating; Aspartate Aminotransferases; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Glioma; Glutamic Acid; Humans; Male; Mice; Mice, Nude; Oxaloacetic Acid; Rats; Rats, Sprague-Dawley; Temozolomide; Tumor Burden

2012
Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma.
    Cell death & disease, 2021, 07-21, Volume: 12, Issue:8

    Topics: Amino Acids; Antineoplastic Agents, Alkylating; Cell Death; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamic Acid; Humans; Kinetics; Neoadjuvant Therapy; Receptors, Metabotropic Glutamate; Temozolomide; Tumor Microenvironment; Xanthenes

2021